Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$29.72 - $45.1 $483,990 - $734,453
-16,285 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $585,934 - $724,356
16,285 New
16,285 $586,000
Q2 2021

Aug 13, 2021

SELL
$37.61 - $48.0 $4.31 Million - $5.5 Million
-114,661 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$44.0 - $67.54 $5.05 Million - $7.74 Million
114,661 New
114,661 $5.25 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Adams Street Partners LLC Portfolio

Follow Adams Street Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Street Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adams Street Partners LLC with notifications on news.